|A global clinical measure of fitness and frailty in elderly people|
K Rockwood, X Song, C MacKnight, H Bergman, DB Hogan, I McDowell, ...
Cmaj 173 (5), 489-495, 2005
|Vitamin E and donepezil for the treatment of mild cognitive impairment|
RC Petersen, RG Thomas, M Grundman, D Bennett, R Doody, S Ferris, ...
New England Journal of Medicine 352 (23), 2379-2388, 2005
|Frailty: an emerging research and clinical paradigm—issues and controversies|
H Bergman, L Ferrucci, J Guralnik, DB Hogan, S Hummel, ...
The Journals of Gerontology Series A: Biological Sciences and Medical …, 2007
|Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials|
M Grundman, RC Petersen, SH Ferris, RG Thomas, PS Aisen, DA Bennett, ...
Archives of neurology 61 (1), 59-66, 2004
|A brief clinical instrument to classify frailty in elderly people|
K Rockwood, K Stadnyk, C MacKnight, L McDowell, R Hébert
Lancet (British edition) 353 (9148), 205-206, 1999
|A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease|
H Feldman, S Gauthier, J Hecker, B Vellas, P Subbiah, E Whalen
Neurology 57 (4), 613-620, 2001
|A reevaluation of the duration of survival after the onset of dementia|
C Wolfson, DB Wolfson, M Asgharian, CE M'Lan, T Østbye, K Rockwood, ...
New England Journal of Medicine 344 (15), 1111-1116, 2001
|Prevalence and outcomes of vascular cognitive impairment|
K Rockwood, C Wentzel, V Hachinski, DB Hogan, C MacKnight, ...
Neurology 54 (2), 447-451, 2000
|Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people|
K Rockwood, S Kirkland, DB Hogan, C MacKnight, H Merry, R Verreault, ...
Archives of neurology 59 (2), 223-227, 2002
|Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging|
K Rockwood, SE Howlett, C MacKnight, BL Beattie, H Bergman, R Hébert, ...
The Journals of Gerontology Series A: Biological Sciences and Medical …, 2004
|Models, definitions, and criteria for frailty|
Conn's handbook of models for human aging, 35-44, 2018
|Measurement, correlates, and health outcomes of medication adherence among seniors|
SA Vik, CJ Maxwell, DB Hogan
Annals of pharmacotherapy 38 (2), 303-312, 2004
|Cognitive impairment in the nondemented elderly: results from the Canadian Study of Health and Aging|
EM Ebly, DB Hogan, IM Parhad
Archives of neurology 52 (6), 612-619, 1995
|Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe|
HH Feldman, RS Doody, M Kivipelto, DL Sparks, DD Waters, RW Jones, ...
Neurology 74 (12), 956-964, 2010
|Progression of impairment in patients with vascular cognitive impairment without dementia|
C Wentzel, K Rockwood, C MacKnight, V Hachinski, DB Hogan, ...
Neurology 57 (4), 714-716, 2001
|Conceptualisation and measurement of frailty in elderly people|
K Rockwood, DB Hogan, C MacKnight
Drugs & aging 17 (4), 295-302, 2000
|Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging|
EM Ebly, IM Parhad, DB Hogan, TS Fung
Neurology 44 (9), 1593-1593, 1994
|The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia|
CJ Patterson, S Gauthier, H Bergman, CA Cohen, JW Feightner, ...
CMAJ: Canadian Medical Association Journal 160 (12), S1, 1999
|Safety and efficacy of galantamine in subjects with mild cognitive impairment|
B Winblad, S Gauthier, L Scinto, H Feldman, GK Wilcock, L Truyen, ...
Neurology 70 (22), 2024-2035, 2008
|The Canadian longitudinal study on aging (CLSA)|
PS Raina, C Wolfson, SA Kirkland, LE Griffith, M Oremus, C Patterson, ...
Canadian Journal on Aging/La Revue canadienne du vieillissement 28 (3), 221-229, 2009